BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 22066718)

  • 1. Identification and characterization of C106R, a novel mutation in the DNA-binding domain of GCMB, in a family with autosomal-dominant hypoparathyroidism.
    Yi HS; Eom YS; Park IeB; Lee S; Hong S; Jüppner H; Mannstadt M; Lee S
    Clin Endocrinol (Oxf); 2012 May; 76(5):625-33. PubMed ID: 22066718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dominant-negative GCMB mutations cause an autosomal dominant form of hypoparathyroidism.
    Mannstadt M; Bertrand G; Muresan M; Weryha G; Leheup B; Pulusani SR; Grandchamp B; Jüppner H; Silve C
    J Clin Endocrinol Metab; 2008 Sep; 93(9):3568-76. PubMed ID: 18583467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and characterization of novel parathyroid-specific transcription factor Glial Cells Missing Homolog B (GCMB) mutations in eight families with autosomal recessive hypoparathyroidism.
    Bowl MR; Mirczuk SM; Grigorieva IV; Piret SE; Cranston T; Southam L; Allgrove J; Bahl S; Brain C; Loughlin J; Mughal Z; Ryan F; Shaw N; Thakker YV; Tiosano D; Nesbit MA; Thakker RV
    Hum Mol Genet; 2010 May; 19(10):2028-38. PubMed ID: 20190276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A missense glial cells missing homolog B (GCMB) mutation, Asn502His, causes autosomal dominant hypoparathyroidism.
    Mirczuk SM; Bowl MR; Nesbit MA; Cranston T; Fratter C; Allgrove J; Brain C; Thakker RV
    J Clin Endocrinol Metab; 2010 Jul; 95(7):3512-6. PubMed ID: 20463099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutational analysis of GCMB, a parathyroid-specific transcription factor, in parathyroid adenoma of primary hyperparathyroidism.
    Mannstadt M; Holick E; Zhao W; Jüppner H
    J Endocrinol; 2011 Aug; 210(2):165-71. PubMed ID: 21642377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel Glial Cells Missing-2 (GCM2) variants in parathyroid disorders.
    Canaff L; Guarnieri V; Kim Y; Wong BYL; Nolin-Lapalme A; Cole DEC; Minisola S; Eller-Vainicher C; Cetani F; Repaci A; Turchetti D; Corbetta S; Scillitani A; Goltzman D
    Eur J Endocrinol; 2022 Feb; 186(3):351-366. PubMed ID: 35038313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A common structural mechanism underlying GCMB mutations that cause hypoparathyroidism.
    Sticht H; Hashemolhosseini S
    Med Hypotheses; 2006; 67(3):482-7. PubMed ID: 16697534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GCMB mutation in familial isolated hypoparathyroidism with residual secretion of parathyroid hormone.
    Thomée C; Schubert SW; Parma J; Lê PQ; Hashemolhosseini S; Wegner M; Abramowicz MJ
    J Clin Endocrinol Metab; 2005 May; 90(5):2487-92. PubMed ID: 15728199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glial cells missing-2 (GCM2) transactivates the calcium-sensing receptor gene: effect of a dominant-negative GCM2 mutant associated with autosomal dominant hypoparathyroidism.
    Canaff L; Zhou X; Mosesova I; Cole DE; Hendy GN
    Hum Mutat; 2009 Jan; 30(1):85-92. PubMed ID: 18712808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Familial isolated hypoparathyroidism caused by a mutation in the gene for the transcription factor GCMB.
    Ding C; Buckingham B; Levine MA
    J Clin Invest; 2001 Oct; 108(8):1215-20. PubMed ID: 11602629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presence and significance of a R110W mutation in the DNA-binding domain of GCM2 gene in patients with isolated hypoparathyroidism and their family members.
    Tomar N; Bora H; Singh R; Gupta N; Kaur P; Chauhan SS; Sharma YD; Goswami R
    Eur J Endocrinol; 2010 Feb; 162(2):407-21. PubMed ID: 19940031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic and clinical characteristics of korean patients with isolated hypoparathyroidism: from the Korean hypopara registry study.
    Park SY; Eom YS; Choi B; Yi HS; Yu SH; Lee K; Jin HS; Chung YS; Jung TS; Lee S
    J Korean Med Sci; 2013 Oct; 28(10):1489-95. PubMed ID: 24133354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gata3-deficient mice develop parathyroid abnormalities due to dysregulation of the parathyroid-specific transcription factor Gcm2.
    Grigorieva IV; Mirczuk S; Gaynor KU; Nesbit MA; Grigorieva EF; Wei Q; Ali A; Fairclough RJ; Stacey JM; Stechman MJ; Mihai R; Kurek D; Fraser WD; Hough T; Condie BG; Manley N; Grosveld F; Thakker RV
    J Clin Invest; 2010 Jun; 120(6):2144-55. PubMed ID: 20484821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autosomal Dominant PTH Gene Signal Sequence Mutation in a Family With Familial Isolated Hypoparathyroidism.
    Cinque L; Sparaneo A; Penta L; Mencarelli A; Rogaia D; Esposito S; Fabrizio FP; Baorda F; Verrotti A; Falorni A; Stangoni G; Hendy GN; Guarnieri V; Prontera P
    J Clin Endocrinol Metab; 2017 Nov; 102(11):3961-3969. PubMed ID: 28938448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of GATA3 mutations in the hypoparathyroidism, deafness, and renal dysplasia (HDR) syndrome.
    Nesbit MA; Bowl MR; Harding B; Ali A; Ayala A; Crowe C; Dobbie A; Hampson G; Holdaway I; Levine MA; McWilliams R; Rigden S; Sampson J; Williams AJ; Thakker RV
    J Biol Chem; 2004 May; 279(21):22624-34. PubMed ID: 14985365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A missense GATA3 mutation, Thr272Ile, causes the hypoparathyroidism, deafness, and renal dysplasia syndrome.
    Gaynor KU; Grigorieva IV; Nesbit MA; Cranston T; Gomes T; Gortner L; Thakker RV
    J Clin Endocrinol Metab; 2009 Oct; 94(10):3897-904. PubMed ID: 19723756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional characterization of GATA3 mutations causing the hypoparathyroidism-deafness-renal (HDR) dysplasia syndrome: insight into mechanisms of DNA binding by the GATA3 transcription factor.
    Ali A; Christie PT; Grigorieva IV; Harding B; Van Esch H; Ahmed SF; Bitner-Glindzicz M; Blind E; Bloch C; Christin P; Clayton P; Gecz J; Gilbert-Dussardier B; Guillen-Navarro E; Hackett A; Halac I; Hendy GN; Lalloo F; Mache CJ; Mughal Z; Ong AC; Rinat C; Shaw N; Smithson SF; Tolmie J; Weill J; Nesbit MA; Thakker RV
    Hum Mol Genet; 2007 Feb; 16(3):265-75. PubMed ID: 17210674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive next-generation sequencing analyses of hypoparathyroidism: identification of novel GCM2 mutations.
    Mitsui T; Narumi S; Inokuchi M; Nagasaki K; Nakazawa M; Sasaki G; Hasegawa T
    J Clin Endocrinol Metab; 2014 Nov; 99(11):E2421-8. PubMed ID: 25137426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Familial hypoparathyroidism: identification of a novel gain of function mutation in transmembrane domain 5 of the calcium-sensing receptor.
    Watanabe T; Bai M; Lane CR; Matsumoto S; Minamitani K; Minagawa M; Niimi H; Brown EM; Yasuda T
    J Clin Endocrinol Metab; 1998 Jul; 83(7):2497-502. PubMed ID: 9661634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The hypoparathyroidism-associated mutation in Drosophila Gcm compromises protein stability and glial cell formation.
    Xi X; Lu L; Zhuge CC; Chen X; Zhai Y; Cheng J; Mao H; Yang CC; Tan BC; Lee YN; Chien CT; Ho MS
    Sci Rep; 2017 Jan; 7():39856. PubMed ID: 28051179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.